2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia.

Authors :: Landmesser, Ulf
Chapman, M John
Stock, Jane K
Amarenco, Pierre
Belch, Jill J F
Borén, Jan
Farnier, Michel
Ference, Brian A
Gielen, Stephan
Graham, Ian
Source :: European Heart Journal; 4/7/2018, Vol. 39 Issue 14, p1131-1143, 13p, 5 Diagrams, 1 Chart, 1 Graph
Publication Year :: 2018

Full Text Access

Tools